Response

Affiliations

¹ Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada. Electronic address: samy.suissa@mcgill.ca.
² Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada.

Comment

Samy Suissa et al. Chest. 2020 Aug.

. 2020 Aug;158(2):832-833.

doi: 10.1016/j.chest.2020.03.046.

¹ Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada. Electronic address: samy.suissa@mcgill.ca.
² Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada.

No abstract available

Comment on

Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
Suissa S, Dell'Aniello S, Ernst P. Suissa S, et al. Chest. 2020 Apr;157(4):846-855. doi: 10.1016/j.chest.2019.11.007. Epub 2019 Nov 22. Chest. 2020. PMID: 31759966
Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink.
Rothnie KJ, Quint JK. Rothnie KJ, et al. Chest. 2020 Aug;158(2):831-832. doi: 10.1016/j.chest.2020.02.069. Chest. 2020. PMID: 32768071 No abstract available.